Clinical trial
The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
NCT01080170 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
- Lead sponsor
- University of Pittsburgh
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- June 30, 2013
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer